n | Avoid Going to the Doctor’s Office | Avoid Getting Laboratory Tests | Avoid Other Testsa | Had a Telehealth Visit | Stopped Medicationsb | |
---|---|---|---|---|---|---|
All patients | 1517 | 858 (56.6) | 641 (42.3) | 546 (36.0) | 448 (29.5) | 169/1132 (14.9) |
RA | 925 | 515 (55.7) | 377 (40.8) | 314 (33.9) | 263 (28.4) | 97/733 (13.2) |
PsA | 299 | 168 (56.2) | 124 (41.5) | 113 (37.8) | 95 (31.8) | 41/213 (19.2)c |
AS | 185 | 104 (56.2) | 82 (44.3) | 68 (36.8) | 54 (29.2) | 22/115 (19.1) |
SLE | 108 | 71 (65.7)c | 58 (53.7)c | 51 (47.2)c | 36 (33.3) | 9/71 (12.7) |
No biologic or JAKi | 569 | 344 (60.5) | 261 (45.9) | 207 (36.4) | 162 (28.5) | 33/307 (10.7) |
Biologic or JAKi | 948 | 514 (54.2)c | 380 (40.1)c | 339 (35.8) | 286 (30.2) | 136/825 (16.5)c |
Urban county | 1240 | 718 (57.9) | 543 (43.8) | 453 (36.5) | 381 (30.7) | 146/933 (15.6) |
Rural county | 214 | 108 (50.5)c | 73 (34.1)c | 68 (31.8) | 48 (22.4)c | 19/156 (12.2) |
Median household income by zip code | ||||||
Lowest tertile | 274 | 147 (53.6) | 112 (40.9) | 105 (38.3) | 77 (28.1) | 35/200 (17.5) |
Middle tertile | 483 | 273 (56.5) | 200 (41.4) | 152 (31.5) | 134 (27.7) | 39/360 (10.8)c |
Highest tertile | 703 | 410 (58.3) | 308 (43.8) | 267 (38.0) | 222 (31.6) | 92/533 (17.3) |
Education by zip code (% greater than high school) | ||||||
Lowest tertile | 168 | 93 (55.4) | 73 (43.5) | 69 (41.1) | 51 (30.4) | 25/117 (21.4) |
Middle tertile | 445 | 253 (56.9) | 189 (42.5) | 155 (34.8) | 117 (26.3) | 44/328 (13.4)c |
Highest tertile | 850 | 486 (57.2) | 359 (42.2) | 301 (35.4) | 265 (31.2) | 97/650 (14.9) |
County COVID-19 cases per capita | ||||||
Lowest tertile | 518 | 282 (54.4) | 200 (38.6) | 178 (34.4) | 143 (27.6) | 54/379 (14.2) |
Middle tertile | 480 | 276 (57.5) | 204 (42.5) | 159 (33.1) | 147 (30.6) | 57/368 (15.5) |
Highest tertile | 456 | 268 (58.8) | 212 (46.5)c | 184 (40.4) | 139 (30.5) | 54/342 (15.8) |
Concerned about COVID-19 | ||||||
Not at all, slightly, or somewhat concerned | 304 | 117 (38.5) | 86 (28.3) | 74 (24.3) | 78 (25.7) | 19/218 (8.7) |
Moderately or extremely concerned | 1213 | 741 (61.1)c | 555 (45.8)c | 472 (38.9)c | 370 (30.5) | 150/914 (16.4)c |
Proportions compared to the reference groups (RA, no biologics/JAKi, urban residence, lowest tertile of median household income, education, or COVID-19 cases per capita, and lower COVID-19 concern) using univariate logistic regression (OR and CI in Supplementary Table 2, available with the online version of this article).
↵a Other tests include radiographs.
↵b Proportion stopping medications is among patients who were receiving immunosuppression/immunomodulatory therapy and did not report a respiratory illness or diagnosis of COVID-19.
↵c P < 0.05 versus the reference group. AS: ankylosing spondylitis; COVID-19: coronavirus disease 2019; JAKi: Janus kinase inhibitor; PsA: psoriatic arthritis; RA: rheumatoid arthritis; SLE: systemic lupus erythematosus.